You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Coronavirus disease 2019

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moderate to Severe Chronic Plaque-type Psoriasis Trial in Worldwide (secukinumab low dose, secukinumab high dose)

Active, not recruiting
Has Results
  • Moderate to Severe Chronic Plaque-type Psoriasis
  • secukinumab low dose
  • secukinumab high dose
  • Fountain Valley, California
  • +22 more
Dec 24, 2022

Common Bile Duct Stones : What Are Limits and When Should we

Completed
  • Laparoscopic
  • Common Bile Duct Stone With Chronic Cholecystitis
  • Laparoscopic common bile duct exploration.
  • Montpellier, France
    Uhmontpellier
Sep 1, 2020

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Milano, Italy
  • +1 more
Jan 16, 2023

Peripheral Vascular Diseases Trial in Worldwide (Any eligible commercially available Boston Scientific Corporation (BSC)

Recruiting
  • Peripheral Vascular Diseases
  • Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
  • Jonesboro, Arkansas
  • +63 more
Jan 17, 2023

Ulcerative Colitis Trial in Zerifin (Performing anorectal manometry)

Recruiting
  • Ulcerative Colitis
  • Performing anorectal manometry
  • Zerifin, Israel
    Shamir Medical Center (Assaf Harofeh)
Aug 3, 2022

Extremes of Coronary Artery Disease and Normality:CAD Extremes

Not yet recruiting
  • Coronary Artery Disease
  • Blood draw
  • (no location specified)
Mar 7, 2023

Different Susceptibility to SARS CoV-2 Infection Among Health

Completed
  • Health Care Worker Patient Transmission
  • +3 more
  • Susceptibility to infection
  • Madrid, Spain
    Hospital Ramon y Cajal
Oct 23, 2021

Mammography, Vascular Calcification Trial in New York (BAC-Enhanced Letter, Waitlist Control)

Recruiting
  • Mammography
  • Vascular Calcification
  • BAC-Enhanced Letter
  • Waitlist Control
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 1, 2022

Neural Tube Defects, Folic Acid Deficiency, Fortification Trial in Birmingham (Salt with folic acid and iodine)

Active, not recruiting
  • Neural Tube Defects
  • +2 more
  • Salt with folic acid and iodine
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 6, 2023

Endometriosis Trial in Afula (• Endothelial function using ENDOPAT system)

Recruiting
  • Endometriosis
  • • Endothelial function using ENDOPAT system
  • Afula, Israel
    Haemek Medical Center
Jan 24, 2022

Myopia Trial in Shanghai (Weak outdoor light, Strong outdoor light)

Recruiting
  • Myopia
  • Weak outdoor light
  • Strong outdoor light
  • Shanghai, Shanghai, China
    Shanghai Eye Disease Prevention and Treatment Center
Oct 25, 2022

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)

Completed
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +159 more
Dec 19, 2022

Diabetes, Type 2, Randomized Controlled Trial Trial in Aarhus N (Lev Livet)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Randomized Controlled Trial
  • Lev Livet
  • Aarhus N, Denmark
    Steno Diabetes Center Aarhus
Oct 23, 2023

Chronic Kidney Diseases Trial in Houston (1. Welcome package, 2. Welcome information (phone or text), 3. Produce delivery +

Not yet recruiting
  • Chronic Kidney Diseases
  • 1. Welcome package
  • +4 more
  • Houston, Texas
  • +2 more
Jul 31, 2023

Clinical Care of Autosomal Polycystic Kidney Disease:

Completed
  • ADPKD
    • New York, New York
      The Rogosin Institute
    Feb 28, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Prognostic Stage IV Breast Cancer AJCC v8
    • Pembrolizumab
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2023

    Blood Platelet Indices,Platelet Aggregation in Activity of IBD

    Not yet recruiting
    • Bowel Disease
    • Inflammatory Bowel Diseases
    • Infliximab
    • (no location specified)
    Jun 4, 2022

    Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)

    Completed
    • Type2 Diabetes Mellitus
    • Herlev, Denmark
      Herlev og Gentofte Hospital
    Aug 17, 2022

    Stargardt Disease 1 Trial in Worldwide (Zimura, Sham)

    Recruiting
    • Stargardt Disease 1
    • Phoenix, Arizona
    • +41 more
    Sep 7, 2022

    Rheumatoid Arthritis, Ankylosing Spondylitis, Fibromyalgia Trial in Upper Nyack

    Recruiting
    • Rheumatoid Arthritis
    • +12 more
      • Upper Nyack, New York
        Global Healthy Living Foundation
      Dec 23, 2022

      Advanced Solid Tumor Trial in Spain, United Kingdom, United States (AFM24, Atezolizumab 840 MG in 14 ML Injection)

      Recruiting
      • Advanced Solid Tumor
      • AFM24
      • Atezolizumab 840 MG in 14 ML Injection
      • Los Angeles, California
      • +5 more
      Dec 5, 2022

      Conventional Hemodialysis and Renal Transplantation on Global

      Active, not recruiting
      • Cardiovascular Diseases
      • +2 more
        • Iasi, Romania
          Gr T Popa University of Medicine and Pharmacy
        Jan 8, 2023

        Nonsquamous NSCLC Trial in Yichang (Sintilimab, Docetaxel, Pemetrexed)

        Recruiting
        • Nonsquamous Non-Small Cell Lung Cancer
        • Yichang, Hubei, China
          Department of Medical Oncology, Central Hospital of Yichang City
        Nov 5, 2021

        Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

        Recruiting
        • Basal Cell Carcinoma
        • +10 more
        • Nijmegen, Gelderland, Netherlands
        • +7 more
        Jul 14, 2022

        Asthma, Respiratory Tract Disease, Lung Diseases Trial in Houston (Exposure-Reduction Intervention)

        Active, not recruiting
        • Asthma
        • +3 more
        • Exposure-Reduction Intervention
        • Houston, Texas
          Baylor College of Medicine
        Jun 2, 2022